Smith & Nephew (SNN) Other Non-Current Assets (2009 - 2025)

Smith & Nephew (SNN) posted quarterly Other Non-Current Assets of $164.0 million for Q4 2025, up 583.33% year-on-year from $24.0 million in Q4 2024, and up 234.69% on a QoQ basis from $49.0 million in Q2 2025.

Smith & Nephew (SNN) Other Non-Current Assets (2009 - 2025) Analysis & Trends

Smith & Nephew (SNN) has reported Other Non-Current Assets for 12 consecutive years, with $164.0 million the latest figure, recorded in Q4 2025.

  • Quarterly Other Non-Current Assets rose 583.33% year-over-year to $164.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $164.0 million (up 583.33% YoY) and the FY2025 annual result came in at $164.0 million, up 583.33% from the prior year.
  • Other Non-Current Assets climbed to $164.0 million in Q4 2025 per SNN's latest filing, from $49.0 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for SNN reached as high as $164.0 million in Q4 2025 and fell as low as $12.0 million in Q4 2022.
  • A 5-year average of $42.7 million and a median of $18.0 million in 2023 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2021 — Other Non-Current Assets plunged 54.55% — and 2025, when it surged 583.33%.
  • Year by year, Other Non-Current Assets stood at $15.0 million in 2021, then fell by 20.0% to $12.0 million in 2022, then jumped by 50.0% to $18.0 million in 2023, then jumped by 33.33% to $24.0 million in 2024, then jumped by 583.33% to $164.0 million in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $164.0 million, $49.0 million, and $24.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 3.17 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 4.15 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 2.05 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 738.90 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 285.90 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 828.89 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 2.25 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 164.00 Mn
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn 211.40 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 164.00 Mn
Jun 28, 2025 49.00 Mn
Dec 31, 2024 24.00 Mn
Jun 29, 2024 17.00 Mn
Dec 31, 2023 18.00 Mn
Dec 31, 2022 12.00 Mn
Dec 31, 2021 15.00 Mn
Dec 31, 2020 33.00 Mn
Jun 30, 2020 30.00 Mn
Dec 31, 2019 35.00 Mn
Jun 29, 2019 33.00 Mn
Dec 31, 2018 16.00 Mn
Jun 30, 2018 13.00 Mn
Dec 31, 2017 16.00 Mn
Mar 31, 2012 128.00 Mn
Dec 31, 2011 125.00 Mn
Dec 31, 2009 14.00 Mn